Natural non-trasgenic animal models for research in alzheimer's disease

Current Alzheimer Research

Volumn 6, Issue 2, 2009, Pages 171-178

  Sarasa, Manuel ^a   Pesini, Pedro ^a  

^a Araclon Biotech Ltd   (Spain)

Author keywords

A ; APP; Chick embryo; Dog; Dolphin; Rabbit; Rat

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHICK EMBRYO; COGNITIVE DEFECT; DOG; DOLPHIN; ENZYME METABOLISM; ENZYME REGULATION; LEARNING DISORDER; MEMORY DISORDER; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIMATE; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; REVIEW; SENILE PLAQUE; SPECIES DIFFERENCE; TRANSGENICS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHICK EMBRYO; DISEASE MODELS, ANIMAL; DOGS; HUMANS; RABBITS; RATS;

EID: 64549150594     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720509787602834     Document Type: Review

References (91)

1. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42: 23-36 (2004).
2. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4: 231-2 (2001).
3. Muller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, Rulicke T, et al. Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell 79: 755-65 (1994).
4. Ring S, Weyer SW, Kilian SB, Waldron E, Pietrzik CU, Filippov MA, et al. The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J Neurosci 27: 7817-26 (2007).
5. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rulicke T, et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 20: 7951-63 (2000).
6. Gómez-Isla T and Irizarry MC. Alzheimer's disease and transgenic mouse models. In: Handbook of neuropsychology (Boller F, Kappa S. Eds). Elsevier, Amsterdam, pp. 23-37 (2001).
7. Mudher A and Lovestone S. Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci 25: 22-6 (2002).
8. Price DL and Sisodia SS. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21: 479-505 (1998).
9. Lannfelt L, Folkesson R, Mohammed AH, Winblad B, Hellgren D, Duff K, et al. Alzheimer's disease: molecular genetics and transgenic animal models. Behav Brain Res 57: 207-13 (1993).
10. Price DL and Sisodia SS. Cellular and molecular biology of Alzheimer's disease and animal models. Annu Rev Med 45: 435-46 (1994).
11. Bayer TA and Wirths O. Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav 7 (Suppl 1): 6-11 (2008).
12. Higgins GA and Jacobsen H. Transgenic mouse models of Alzheimer's disease: phenotype and application. Behav Pharmacol 14: 419-38 (2003).
13. Dodart JC, Mathis C, Bales KR and Paul SM. Does my mouse have Alzheimer's disease? Genes Brain Behav 1: 142-55 (2002).
14. van Dooren T, Dewachter I, Borghgraef P and van Leuven F. Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects. Subcell Biochem 38: 45-63 (2005).
15. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, et al. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6: 143-50 (2000).
16. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657-65 (2000).
17. Gonzalo-Ruiz A, Gonzalez I and Sanz-Anquela JM. Effects of beta-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat. J Chem Neuroanat 26: 153-69 (2003).
18. Gonzalo-Ruiz A, Sanz JM, Arevalo J, Geula C and Gonzalo P. Amyloid beta peptide-induced cholinergic fibres loss in the cerebral cortex of the rat is modified by diet high in lipids and by age. J Chem Neuroanat 29: 31-48 (2005).
19. Du P, Wood KM, Rosner MH, Cunningham D, Tate B and Geoghegan KF. Dominance of amyloid precursor protein sequence over host cell secretases in determining beta-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry. J Pharmacol Exp Ther 320: 1144-52 (2007).
20. Sola C, Garcia-Ladona FJ, Sarasa M, Mengod G, Probst A, Palacios G, et al. Beta APP gene expression is increased in the rat brain after motor neuron axotomy. Eur J Neurosci 5: 795-808 (1993).
21. Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci 25: 1219-25 (2005).
22. Anliker B and Muller U. The functions of mammalian amyloid precursor protein and related amyloid precursor-like proteins. Neurodegener Dis 3: 239-46 (2006).
23. Koo EH. The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog? Traffic 3: 763-70 (2002).
24. Sarasa M, Sorribas V, Terradoa1 J, Climent S, Palacios JM and Mengod G. Alzheimer beta-amyloid precursor proteins display specific patterns of expression during embryogenesis. Mech Dev 94: 233-6 (2000).
25. Beck M, Bigl V and Rossner S. Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo. Neurochem Res 28: 637-44 (2003).
26. Johnstone EM, Chaney MO, Norris FH, Pascual R and Little SP. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res 10: 299-305 (1991).
27. Sparks DL and Schreurs BG. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci USA 100: 11065-9 (2003).
28. Sparks DL. Cholesterol metabolism and brain amyloidosis: evidence for a role of copper in the clearance of Abeta through the liver. Curr Alzheimer Res 4: 165-9 (2007).
29. Sparks DL, Friedland R, Petanceska S, Schreurs BG, Shi J, Perry G, et al. Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. J Nutr Health Aging 10: 247-54 (2006).
30. Ghribi O, Golovko MY, Larsen B, Schrag M and Murphy EJ. Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem 99: 438-49 (2006).
31. Ghribi O, Larsen B, Schrag M and Herman MM. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200: 460-7 (2006).
32. Woodruff-Pak DS, Agelan A and Del Valle L. A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels. J Alzheimers Dis 11: 371-83 (2007).
33. Carrodeguas JA, Rodolosse A, Garza MV, Sanz-Clemente A, Perez-Pé R, Lacosta AM, et al. The chick embryo appears as a natural model for research in beta-amyloid precursor protein processing. Neuroscience 134: 1285-300 (2005).
34. Dani SU. Mechanisms of aging: A survey. In: (Dani SU. Hori A and Walter GF. Eds.). Principles of Neural Aging Elsevier, Amsterdam, pp. 5-18 (1997)
35. Speakman JR. Body size, energy metabolism and lifespan. J Exp Biol 208: 1717-30 (2005).
36. Speakman JR, van Acker A and Harper EJ. Age-related changes in the metabolism and body composition of three dog breeds and their relationship to life expectancy. Aging cell 2: 265-75 (2003).
37. Sutter NB, Bustamante CD, Chase K, Gray MM, Zhao K, Zhu L, et al. A single IGF1 allele is a major determinant of small size in dogs. Science 316: 112-5 (2007).
38. Hare B, Brown M, Williamson C and Tomasello M. The domestication of social cognition in dogs. Science 298: 1634-6 (2002).
39. Hare B and Tomasello M. Human-like social skills in dogs? Trends Cogn Sci 9: 439-44 (2005).
40. Overall KL. Clinical behavioral medicine for small animals. St. Louis. Missouri: Mosby (1997).
41. Pageat P. Patologia del comportamiento del perro. 2nd ed. Barcelona: Pulso (2000).
42. Hu J, Chen H and Li Y. Development of a gas chromatography-time-of-flight mass spectrometry method for the determination of buagafuran, a promising antianxiety drug in dog blood. J Pharm Biomed Anal 47: 383-7 (2008).
43. Cuyckens F, Balcaen LI, De Wolf K, De Samber B, Van Looveren C, Hurkmans R, et al. Use of the bromine isotope ratio in HPLC-ICP-MS and HPLC-ESI-MS analysis of a new drug in development. Anal Bioanal Chem 390: 1717-29 (2008).
44. Landsberg G. Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs. Prog Neuropsychopharmacol Biol Psychiatry 29: 471-9 (2005).
45. Milgram NW, Zicker SC, Head E, Muggenburg BA, Murphey H, Ikeda-Douglas CJ, et al. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging 23: 737-45 (2002).
46. Siwak CT, Tapp PD, Head E, Zicker SC, Murphey HL, Muggenburg BA, et al. Chronic antioxidant and mitochondrial cofactor administration improves discrimination learning in aged but not young dogs. Prog Neuropsychopharmacol Biol Psychiatry 29: 461-9 (2005).
47. Head E. Combining an antioxidant-fortified diet with behavioral enrichment leads to cognitive improvement and reduced brain pathology in aging canines: strategies for healthy aging. Ann N Y Acad Sci 1114: 398-406 (2007).
48. Araujo JA, Studzinski CM and Milgram NW. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. Prog Neuropsychopharmacol Biol Psychiatry 29: 411-22 (2005).
49. Siwak CT, Gruet P, Woehrle F, Muggenburg BA, Murphey HL and Milgram NW. Comparison of the effects of adrafinil, propentofylline, and nicergoline on behavior in aged dogs. Am J Vet Res 61: 1410-4 (2000).
50. Siwak-Tapp CT, Head E, Muggenburg BA, Milgram NW and Cotman CW. Region specific neuron loss in the aged canine hippocampus is reduced by enrichment. Neurobiol Aging 29: 39-50 (2008).
51. Opii WO, Joshi G, Head E, Milgram NW, Muggenburg BA, Klein JB, et al. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with anti-oxidants and a program of behavioral enrichment: Relevance to Alzheimer's disease. Neurobiol Aging 29: 51-70 (2008).
52. Head E, Liu J, Hagen TM, Muggenburg BA, Milgram NW, Ames BN, et al. Oxidative damage increases with age in a canine model of human brain aging. J Neurochem 82: 375-81 (2002).
53. Cummings BJ, Head E, Ruehl W, Milgram NW and Cotman CW. The canine as an animal model of human aging and dementia. Neurobiol Aging 17: 259-68 (1996).
54. Tapp PD, Siwak CT, Estrada J, Holowachuk D and Milgram NW. Effects of age on measures of complex working memory span in the beagle dog (Canis familiaris) using two versions of a spatial list learning paradigm. Learn Mem 10: 148-60 (2003).
55. Adams B, Chan A, Callahan H, Siwak C, Tapp D, Ikeda-Douglas C, et al. Use of a delayed non-matching to position task to model age-dependent cognitive decline in the dog. Behav Brain Res 108: 47-56 (2000).
56. Head E, Mehta R, Hartley J, Kameka M, Cummings BJ, Cotman CW, et al. Spatial learning and memory as a function of age in the dog. Behav Neurosci 109: 851-8 (1995).
57. Siwak CT, Tapp PD and Milgram NW. Effect of age and level of cognitive function on spontaneous and exploratory behaviors in the beagle dog. Learn Mem 8: 317-25 (2001).
58. Head E, Callahan H, Muggenburg BA, Cotman CW and Milgram NW. Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol Aging 19: 415-25 (1998).
59. Head E, McCleary R, Hahn FF, Milgram NW and Cotman CW. Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging 21: 89-96 (2000).
60. Cummings BJ, Head E, Afagh AJ, Milgram NW and Cotman CW. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 66: 11-23 (1996).
61. Colle M-A, Hauw J-J, Crespeau F, Uchihara T, Akiyama H, Checler F, et al. Vascular and parenchymal Abeta deposition in the aging dog: correlation with behavior. Neurobiol Aging 21: 695-704 (2000).
62. Pugliese M, Geloso MC, Carrasco JL, Mascort J, Michetti F and Mahy N. Canine cognitive deficit correlates with diffuse plaque maturation and S100beta (-) astrocytosis but not with insulin cerebrospinal fluid level. Acta Neuropathol (Berl) 111: 519-28 (2006).
63. Rofina JE, van Ederen AM, Toussaint MJ, Secreve M, van der Spek A, van der Meer I, et al. Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease. Brain Res 1069: 216-26 (2006).
64. Neilson JC, Hart BL, Cliff KD and Ruehl WW. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 218: 1787-91 (2001).
65. Bain MJ, Hart BL, Cliff KD and Ruehl WW. Predicting behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 218: 1792-5 (2001).
66. Hou Y, White RG, Bobik M, Marks JS and Russell MJ. Distribution of beta-amyloid in the canine brain. Neuroreport 8: 1009-12 (1997).
67. Yoshino T, Uchida K, Tateyama S, Yamaguchi I, Nakayama H and Goto N. A retrospective study of canine senile plaques and cerebral amyloid angiopathy. Vet Pathol 33: 230-4 (1996).
68. Satou T, Cummings BJ, Head E, Nielson KA, Hahn FF, Milgram NW, et al. The progression of beta-amyloid deposition in the frontal cortex of the aged canine. Brain Res 774: 35-43 (1997).
69. Papaioannou N, Tooten PC, van Ederen AM, Bohl JR, Rofina J, Tsangaris T, et al. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 8: 11-21 (2001).
70. Wisniewski T, Lalowski M, Bobik M, Russell M, Strosznajder J and Frangione B. Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. Biochem J 313( Pt 2): 575-80 (1996).
71. Pugliese M, Mascort J, Mahy N and Ferrer I. Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits. Acta Neuropathol (Berl) 112: 175-83 (2006).
72. Wegiel J, Wisniewski HM and Soltysiak Z. Region-and cell-type-specific pattern of tau phosphorylation in dog brain. Brain Res 802: 259-66 (1998).
73. Wegiel J, Wisniewski HM, Dziewiatkowski J, Tarnawski M, Dziewiatkowska A, Morys J, et al. Subpopulation of dogs with severe brain parenchymal beta amyloidosis distinguished with cluster analysis. Brain Res 728: 20-6 (1996).
74. Russell MJ, White R, Patel E, Markesbery WR, Watson CR and Geddes JW. Familial influence on plaque formation in the beagle brain. Neuroreport 3: 1093-6 (1992).
75. Swerdlow RH. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol Aging 28: 1465-80 (2007).
76. Head E, Barrett EG, Murphy MP, Das P, Nistor M, Sarsoza F, et al. Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Abeta. Vaccine 24: 2824-34 (2006).
77. Menendez L, Insua D, Rois JL, Santamarina G, Suarez ML and Pesini P. The immunohistochemical localization of neuronal nitric oxide synthase in the basal forebrain of the dog. J Chem Neuroanat 31: 200-9 (2006).
78. Insua D, Suarez M-L, Santamarina G, Sarasa M and Pesini P. Dogs with canine counterpart of Alzheimer's disease lose noradrenergic neurons. Neurobiol Aging (2008). In press.
79. Martin LJ, Pardo CA, Cork LC and Price DL. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 145: 1358-81 (1994).
80. Lemere CA, Oh J, Stanish HA, Peng Y, Pepivani I, Fagan AM, et al. Cerebral amyloid-Beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease? Rejuvenation Res 11: 321-32 (2008).
81. Gearing M, Tigges J, Mori H and Mirra SS. beta-Amyloid (A beta) deposition in the brains of aged orangutans. Neurobiol Aging 18: 139-46 (1997).
82. Schultz C, Hubbard GB, Rub U, Braak E and Braak H. Age-related progression of tau pathology in brains of baboons. Neurobiol Aging 21: 905-12 (2000).
83. Bons N, Rieger F, Prudhomme D, Fisher A and Krause KH. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease? Genes Brain Behav 5: 120-130 (2006).
84. Rosen RF, Farberg AS, Gearing M, Dooyema J, LongPM, Anderson DC, et al. Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol 509: 259-270 (2008).
85. Braak H, Braak E and Strothjohann M. Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett 171: 1-4 (1994).
86. Nelson PT, Greenberg SG and Saper CB. Neurofibrillary tangles in the cerebral cortex of sheep. Neurosci Lett 170: 187-90 (1994).
87. Nelson PT and Saper CB. Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep. Neurobiol Aging 16: 315-23 (1995).
88. Roertgen KE, Parisi JE, Clark HB, Barnes DL, O'Brien TD and Johnson KH. A beta-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo). Neurobiol Aging 17: 243-7 (1996).
89. Cork LC, Powers RE, Selkoe DJ, Davies P, Geyer JJ and Price DL. Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 47: 629-41 (1988).
90. Lemere CA, Beierschmitt A, Iglesias M, Spooner ET, Bloom JK, Leverone JF, et al. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. Am J Pathol 165: 283-97 (2004).
91. Gandy S, DeMattos RB, Lemere CA, Heppner FL, Leverone J, Aguzzi A, et al. Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta). Mech Ageing Dev 125: 149-51 (2004).